Hsin Yang Liu
Corporate Officer/Principal bei TSH BIOPHARM CORPORATION LIMITED
Aktive Positionen von Hsin Yang Liu
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TSH BIOPHARM CORPORATION LIMITED | Corporate Officer/Principal | - | - |
| Direktor/Vorstandsmitglied | 24.06.2011 | 31.03.2020 | |
| Independent Dir/Board Member | 24.06.2011 | - | |
| Investor Relations Kontakt | 01.04.2020 | - | |
| Public Communications Contact | 01.04.2020 | - |
Karriereverlauf von Hsin Yang Liu
Ehemalige bekannte Positionen von Hsin Yang Liu
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| REBER GENETICS CO LTD | Direktor/Vorstandsmitglied | 25.02.2014 | - |
| BODY ORGAN BIOMEDICAL CORP | Verwaltungsdirektor | 01.05.2011 | - |
| Comptroller/Controller/Auditor | 01.05.2011 | - | |
| Finanzdirektor/CFO | 01.05.2011 | - | |
| Public Communications Contact | 01.05.2011 | - |
Ausbildung von Hsin Yang Liu
| National Taiwan University | Graduate Degree |
| Nankai University | Doctorate Degree |
Statistik
International
| Taiwan | 5 |
| China | 2 |
Operativ
| Public Communications Contact | 2 |
| Director/Board Member | 2 |
| Chief Administrative Officer | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TSH BIOPHARM CORPORATION LIMITED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Body Organ Biomedical Corp.
 Body Organ Biomedical Corp. BiotechnologyHealth Technology Body Organ Biomedical Corp. engages in the research, development, manufacture and sales of biomedical devices. It also provides regenerative solutions to restore tissue damage in orthopedics, dentistry, ophthalmology, reconstructive and general surgery. The company was founded on May 4, 2007 and is headquartered in Taipei, Taiwan. | Health Technology |
Reber Genetics Co., Ltd.
 Reber Genetics Co., Ltd. Pharmaceuticals: MajorHealth Technology Reber Genetics Co., Ltd. engages in the research, development, production, and sale of animal vaccines. Its products include PRRS and PCV2 subunit vaccines. The company was founded on April 18, 2008 and is headquartered in Taipei, Taiwan. | Health Technology |
- Börse
- Insiders
- Hsin Yang Liu
- Erfahrung
